CDH2 and neoplasm: EMT, a well-characterized embryological process, has been identified to play a critical role in tumor metastasis, which is characterized by losing epithelial markers (e.g. E-cadherin), and acquiring of mesenchymal markers (e.g. N-cadherin, ZEB2) [5].